HC Wainwright & Co. Maintains Buy on Instil Bio, Raises Price Target to $40
Benzinga Newsdesk 2 years ago
NewsPrice TargetAnalyst Ratings
HC Wainwright & Co. analyst Mitchell Kapoor maintains Instil Bio (NASDAQ:TIL) with a Buy and raises the price target from $25 to $40.
HC Wainwright & Co. analyst Mitchell Kapoor maintains Instil Bio (NASDAQ:TIL) with a Buy and raises the price target from $25 to $40.